Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of mAb 216 With Chemotherapy for the Treatment of Adult Patients With Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia

NCT00313079 is registered in ClinicalTrials.gov with Steven E. Coutre as lead sponsor.

NCT NCT00313079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00313079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of mAb 216 With Chemotherapy for the Treatment of Adult Patients With Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
Lead sponsor
Steven E. Coutre
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2006
Completion date
July 31, 2009
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, leukemia, leukemia, lymphocytic